Absci, the synthetic biology company unlocking the potential of proteins as next-generation therapeutics, announced two strategic hires joining its executive team: Nikhil Goel as Chief Business Officer and Dr. Sarah Korman as General Counsel. “As we continue to innovate and expand our work with partners to create new next-generation proteins, Nikhil and Sarah are well-positioned to help us strategically…